Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Issue of Equity

10 Feb 2014 07:00

RNS Number : 6237Z
First Derivatives PLC
10 February 2014
 

 10th February 2014

 

First Derivatives plc

("First Derivatives" or the "Company")

 

Dealing by Director

Exercise of Options

 

First Derivatives (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services to the capital markets industry, is pleased to announce that, following the exercise of options by a Director and certain employees, 179,167 new ordinary shares of 0.5p each in the Company have been issued and allotted.

 

Accordingly, application has been made for the 179,167 new ordinary shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 13th February 2014.

 

This includes options over 10,000 new ordinary shares exercised by Mr David Anderson, a Non-Executive Director, at a price of 178.5 pence per ordinary share.

 

Following this transaction Mr Anderson retains a holding of 142,500 First Derivatives ordinary shares representing approximately 0.73 per cent. of the issued share capital of the Company. Mr Anderson also has a beneficial interest in share options over 50,000 First Derivatives ordinary shares which represent approximately 0.25 per cent. of the issued share capital of the Company.

 

The new ordinary shares will rank pari passu with the existing shares of the Company. Following this allotment, the total issued share capital of the Company will increase to 19,485,988 ordinary shares.

 

Enquiries:

 

First Derivatives plc

+44(0)28 3025 2242

Brian Conlon, Chief Executive Officer

www.firstderivatives.com

Graham Ferguson, Finance Director

Charles Stanley Securities

+44 (0)20 7149 6000

(Nominated Adviser& Broker)

Russell Cook

Carl Holmes

GoodbodyCorporate Finance

+353 1 667 0420

(ESM Adviser)

Finbarr Griffin

Goodbody Stockbrokers

Linda Hickey

 

Walbrook PR

+44 (0)20 7933 8780

Financial PR

bob.huxford@walbrookpr.com

Bob Huxford

helen.westaway@walbrookpr.com

Helen Westaway

 

About First Derivatives

 

First Derivatives is a global provider of software and consulting services to the financial services industry. With almost 17 years' experience working with leading financial institutions, it continues to deliver technologically advanced products and services that anticipate and respond to the evolving needs of global capital markets.

 

First Derivatives currently employs over 850 people worldwide and counts many of the world's top investment banks, brokers and hedge funds as its customers. It has operations in London, New York, Stockholm, Shanghai, Singapore, Toronto, Sydney, Dublin, Newry and Hong Kong.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEQKODPABKDQBK
Date   Source Headline
9th May 20257:00 amRNSForm 8.3 - FD Technologies plc
8th May 20253:26 pmRNSForm 8.3 - FD Technologies PLC
8th May 20253:22 pmPRNForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20253:20 pmRNSForm 8.3 - FD Technologies plc
8th May 20252:49 pmRNSForm 8.3 FD TECHNOLOGIES PLC
8th May 20251:51 pmRNSForm 8.3 - FD TECHNOLOGIES PLC
8th May 202511:24 amRNSForm 8.3 - FD Technologies PLC
8th May 202511:13 amRNSForm 8.5 (EPT/RI) - FD Technologies plc
8th May 202510:02 amRNSForm 8.5 (EPT/NON-RI) FD Technologies plc
8th May 20259:53 amGNWForm 8.5 (EPT/RI) - FD Technologies Plc
8th May 20257:00 amRNSRECOMMENDED ACQUISITION OF FD TECHNOLOGIES PLC
7th May 202511:26 amRNSStatement regarding Possible Offer
16th Apr 20257:44 amRNSHolding(s) in Company
11th Apr 20251:25 pmRNSIssue of Equity
2nd Apr 20258:49 amRNSIssue of Equity
25th Mar 20257:00 amRNSTrading Statement
7th Mar 20259:24 amRNSHolding(s) in Company
4th Feb 20253:57 pmRNSIssue of Equity
4th Feb 20252:45 pmRNSHolding(s) in Company
3rd Feb 20252:36 pmRNSHolding(s) in Company
3rd Feb 202510:19 amRNSHolding(s) in Company
31st Jan 20254:01 pmRNSHolding(s) in Company
30th Jan 20252:09 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTENDER OFFER RESULTS AND TOTAL VOTING RIGHTS
20th Jan 20257:00 amRNSHolding(s) in Company
15th Jan 20252:20 pmRNSRESULTS OF GENERAL MEETING
8th Jan 20251:36 pmRNSHolding(s) in Company
8th Jan 20257:00 amRNSIssue of Equity
19th Dec 20245:00 pmRNSPublication of Circular Notice of GM
19th Dec 20247:00 amRNSProposed Tender Offer
13th Dec 20244:54 pmRNSIssue of Equity
13th Dec 20247:00 amRNSNotification of Long-Term Incentive Award to PDMR
3rd Dec 20247:00 amRNSCOMPLETION OF DIVESTMENT OF FIRST DERIVATIVE
26th Nov 20247:00 amRNSInterim Results
14th Nov 20247:00 amRNSProposed Divestment - Satisfaction of Conditions
11th Nov 20244:22 pmRNSNotice of Results
7th Nov 20248:54 amRNSHolding(s) in Company
24th Oct 202412:37 pmRNSResult of General Meeting
8th Oct 20245:00 pmRNSPublication of Circular and Notice of GM
8th Oct 20242:35 pmRNSHolding(s) in Company
7th Oct 20247:00 amRNSProposed Divestment
5th Sep 20242:39 pmRNSHolding(s) in Company
1st Aug 20248:43 amRNSTotal Voting Rights
18th Jul 20244:45 pmRNSResult of AGM
9th Jul 20241:56 pmRNSHolding(s) in Company
4th Jul 202410:36 amRNSHolding(s) in Company
2nd Jul 20244:30 pmRNSIssue of Equity
2nd Jul 20242:17 pmRNSHolding(s) in Company
1st Jul 20245:39 pmRNSPDMR Notice and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.